According to the National Cancer Institute, the Non-Hodgkin Lymphoma represents 4.3% of the cancer cases and is the seventh most diagnosed type. In 2018 alone, the National Cancer Institute is expecting over 74,000 non-Hodgkin lymphoma cases, and almost 20,000 of these cases are going to be fatal. The NHL represents 3.3% of all cancer deaths.
These statistics are somewhat shocking as around 2% of men and women are likely to be diagnosed with Non-Hodgkin Lymphoma at some moment in their lives according to recent data. Out of 100,000 people, almost 20 are going to be diagnosed with NHL, and out of 100,000, almost six are going to die due to NHL. It was estimated that 686,042 people were suffering from Non-Hodgkin Lymphoma in the USA in 2015.
Based on the Surveillance, Epidemiology, and End Results Program (SEER) data, only 71.4% of men and women suffering from Non-Hodgkin Lymphoma are going to survive for five years. It is important to mention that this study cannot determine the likelihood for every particular case as people are different and it cannot predict how the drugs and the treatment are going to affect the person.
The SEER also determined that this disease is more likely to affect men than women; it’s also more likely to affect white men and women more than any other race. It was also determined that the median age at diagnosis was 67, while in contrast, people between 20 to 34 years old only have a 3.6% probability of being diagnosed with NHL. In the same report, the median age at death by NHL was 76 years old.
On the positive side, the Non-Hodgkin Lymphoma cases have been dropping 0.7% each year in the last ten years, and the death rates have also dropped 2.2% per year in the last ten years.
Comments